Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Shares Outstanding (2016 - 2025)

Medifast (MED) has disclosed Shares Outstanding for 13 consecutive years, with $11.0 million as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Shares Outstanding fell 6.13% year-over-year to $11.0 million, compared with a TTM value of $11.0 million through Jun 2022, down 6.13%, and an annual FY2021 reading of $11.6 million, down 1.93% over the prior year.
  • Shares Outstanding was $11.0 million for Q2 2022 at Medifast, down from $11.6 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $12.3 million in Q4 2019 and bottomed at $11.0 million in Q2 2022.
  • Average Shares Outstanding over 5 years is $11.9 million, with a median of $11.8 million recorded in 2020.
  • The sharpest move saw Shares Outstanding rose 1.28% in 2019, then decreased 6.13% in 2022.
  • Year by year, Shares Outstanding stood at $12.1 million in 2018, then grew by 1.28% to $12.3 million in 2019, then decreased by 3.67% to $11.8 million in 2020, then decreased by 1.93% to $11.6 million in 2021, then decreased by 4.96% to $11.0 million in 2022.
  • Business Quant data shows Shares Outstanding for MED at $11.0 million in Q2 2022, $11.6 million in Q1 2022, and $11.6 million in Q4 2021.